CGP 37849, >=98% (HPLC)

CGP 37849, >=98% (HPLC)

Application

CGP 37849 may be used in NMDA-mediated cell signaling studies.

Biochem/physiol Actions

CGP 37849 induces phencyclidine-like behavioral syndrome in amygdala-kindled rats that includes ataxia, locomotion and stereotypies.

CGP 37849 is a potent orally active competitive NMDA antagonist and anticonvulsant.

Packaging

5, 25 mg in glass bottle

No detailed specifications are available for this product.

There are no downloads for this product.

Code Description Colour Quality Level InChI key InChI Manufacturer Solubility Form Assay Price Quantity
3574005 CGP 37849, >=98% (HPLC) white to beige 100 BDYHNCZIGYIOGJ-DUXPYHPUSA-N 1S/C6H12NO5P/c1-4(3-13(10,11)12)2-5(7)6(8)9/h2,5H,3,7H2,1H3,(H,8,9)(H2,10,11,12)/b4-2+ SIGMA-ALDRICH H2O: ≥2 mg/mL (warmed) powder ≥98% (HPLC)
£431.79 (exc VAT) per 25MG
-
+
3574006 CGP 37849, >=98% (HPLC) white to beige 100 BDYHNCZIGYIOGJ-DUXPYHPUSA-N 1S/C6H12NO5P/c1-4(3-13(10,11)12)2-5(7)6(8)9/h2,5H,3,7H2,1H3,(H,8,9)(H2,10,11,12)/b4-2+ SIGMA-ALDRICH H2O: ≥2 mg/mL (warmed) powder ≥98% (HPLC)
£115.61 (exc VAT) per 5MG
-
+